ID

40873

Descrição

Study ID: 101468/902 Clinical Study ID: 101468/902 Study Title:A study to evaluate the effect of repeated oral doses of ropinirole on cardiac conduction as assessed by 12-lead electrocardiogram compared to placebo and single oral doses of moxifloxacin (Bayer) as a positive control. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome

Palavras-chave

Versões (1)
  1. 29/05/2020 29/05/2020 -
Titular dos direitos

GlaxoSmithKline

Transferido a

29 de maio de 2020

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Effect of ropinirole on cardiac conduction as assessed by 12-lead electrocardiogram (101468/902)

Inglês

Drug Tolerance; Dose Details

1 Formulários  
Administrative
Descrição

Administrative

Alias
UMLS CUI-1
C1320722
Subject Number
Descrição

Subject Number

Tipo de dados

text

Alias
UMLS CUI [1]
C2348585
Drug Tolerance
Descrição

Drug Tolerance

Alias
UMLS CUI-1
C0013220
Did the patient tolerate 0.125mg/0.25mg?
Descrição

Did the patient tolerate 0.125mg/0.25mg?

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0013220
If patient did not tolerate the dose, enter the reason why
Descrição

If patient did not tolerate the dose, enter the reason why

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0013220
UMLS CUI [1,2]
C0566251
In the Investigator’s opinion, is it safe for the subject to increase to the next dose level?
Descrição

Y - Subject will receive the next dose level. N - Select a dosing strategy from the options below and tick the relevant box:

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1735338
UMLS CUI [1,2]
C1113679
If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:
Descrição

If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C1735338
UMLS CUI [1,2]
C1113679
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0679199
Dose Details
Descrição

Dose Details

Alias
UMLS CUI-1
C0678766
UMLS CUI-2
C1522508
Dose to be attempted:
Descrição

Dose to be attempted:

Tipo de dados

integer

Unidades de medida
  • mg
Alias
UMLS CUI [1]
C3174092
mg
Dose Level Attempt:
Descrição

Dose Level Attempt:

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C3174092
UMLS CUI [1,2]
C0441889
Dose Details - Comments
Descrição

Dose Details - Comments

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0678766
UMLS CUI [1,2]
C1522508
UMLS CUI [1,3]
C0947611
Dose checked and administered by:
Descrição

Dose checked and administered by:

Tipo de dados

text

Alias
UMLS CUI [1,1]
C1283174
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C2348343
Dose checked and witnessed by:
Descrição

Dose checked and witnessed by:

Tipo de dados

text

Alias
UMLS CUI [1,1]
C1283174
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0682356
UMLS CUI [1,4]
C0178602
Voltar ao início da página

Similar models

Drug Tolerance; Dose Details

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Subject Number
Item
Subject Number
text
C2348585 (UMLS CUI [1])
Item Group
Drug Tolerance
C0013220 (UMLS CUI-1)
Did the patient tolerate 0.125mg/0.25mg?
Item
Did the patient tolerate 0.125mg/0.25mg?
boolean
C0013220 (UMLS CUI [1])
If patient did not tolerate the dose, enter the reason why
Item
If patient did not tolerate the dose, enter the reason why
text
C0013220 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
In the Investigator’s opinion, is it safe for the subject to increase to the next dose level?
Item
In the Investigator’s opinion, is it safe for the subject to increase to the next dose level?
boolean
C1735338 (UMLS CUI [1,1])
C1113679 (UMLS CUI [1,2])
Item
If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:
integer
C1735338 (UMLS CUI [1,1])
C1113679 (UMLS CUI [1,2])
C0178602 (UMLS CUI [2,1])
C0679199 (UMLS CUI [2,2])
If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:
Code List
If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:
CL Item
Dose reduce to the dose level below (return to the previous dose level) for a further 1-4 days of dosing at the (1)
CL Item
lower dose level. (2)
CL Item
Administer domperidone to reduce adverse events. ONLY IF THIS IS A SECOND ATTEMPT AT THIS DOSE (3)
CL Item
LEVEL. (4)
CL Item
The investigator decides that the subject has reached their MTD. (5)
Item Group
Dose Details
C0678766 (UMLS CUI-1)
C1522508 (UMLS CUI-2)
Dose to be attempted:
Item
Dose to be attempted:
integer
C3174092 (UMLS CUI [1])
Dose Level Attempt:
Item
Dose Level Attempt:
integer
C3174092 (UMLS CUI [1,1])
C0441889 (UMLS CUI [1,2])
Dose Details - Comments
Item
Dose Details - Comments
text
C0678766 (UMLS CUI [1,1])
C1522508 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
Dose checked and administered by:
Item
Dose checked and administered by:
text
C1283174 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C2348343 (UMLS CUI [1,3])
Dose checked and witnessed by:
Item
Dose checked and witnessed by:
text
C1283174 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0682356 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,4])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial